5: Getting Ready for the IVDR
IVDR Brings Huge Change to Manufacturers Distributing Products in Europe The In Vitro Diagnostic Regulation (IVDR) means enormous upheaval for companies, as now up to 90% of products will need to be r...
11 Maalis 202214min
4: The Why, How, When and What of EU MDR Regulation
Jean has extended experience in all phases of the product lifecycle, driving compliance from concept initiation through to commercialisation and post-market support. He provides Regulatory and Qualit...
4 Helmi 202215min
3: Bayesian Statistics
This episode of PharmaLex Talks features Bruno Boulanger, Senior Director, Global Head Statistics and Data Science at PharmaLex and an award-wining author on Global Statistics and Data Science (link h...
29 Marras 202132min
2: Challenges & Regulatory landscape for ATMPs
Industry experts on ATMPs discuss the challenges and regulatory landscape with respect to the development of ATMPs, and what support and guidance is available from regulatory agencies.
15 Marras 202117min
1: Post Brexit landscape for the pharmaceutical industry
Meeting the regulatory challenges of the post-Brexit pharma landscape In the inaugural PharmaLex Talks podcast, host Elizabeth Hunt chats with Charley Maxwell, Director QMC / Senior Consultant at Ph...
6 Syys 202114min
